Skip to content
★ Sign in to follow
Prenetics Global Ltd logo

Prenetics Global Ltd Stock: price and insider trades · United States

2 insiders bought €856k of shares over the last 90 days, the latest by Rosin Brian J, filed 26 Aug 2026.

Prenetics Global Ltd: what insiders have been doing

Prenetics Global Ltd is a Food & Beverage company. Its directors and officers file their transactions with SEC (Form 4). 5 insiders have disclosed 16 filings since 5 November 2025.

Every open-market trade in the period is a purchase: 5 purchases worth €856k, from 2 insiders, and not a single sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The largest single trade was a purchase of €327k by Rosin Brian J, published on 26 August 2026, equal to 0.10% of the market capitalisation. On the buying side, the filings list 1 finance chief and 1 chief executive among the declarants.

Compared with its exchange (3,179 companies, median 24 filings), a count of 16 filings is below the norm. Since 2026, the database holds 5 purchases and no sales by insiders of the company.

Within a 30-day window, 2 purchases overlapped with buying by a second insider. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. The latest purchase dates back some time: it was published 74 days ago, on 26 August 2026. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade.

In the same sector, recent insider purchases at Davide Campari - Milano N.V. also feature in our signals. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Insider Decl.
16
Thresholds
n/a
Buy Volume
€855,919
5 ops. · all time
Sell Volume
n/a
n/a

Who traded when

BuySale
Danny Sheng Wu Yeung3 buys
Brian J. Rosin2 buys

Since the insiders bought

  • Filed 26 Aug 2026 · 74 days ago · €327k
    -13.3%
    Entry US$26.25 · Close at T+30 US$22.76
  • Filed 24 Aug 2026 · 76 days ago · €118k
    -1.4%
    Entry US$23.25 · Close at T+30 US$22.93

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Analyst consensus: bullish or bearish?

Analysts rate Prenetics Global Ltd Strong Buy (bullish), based on 9 analysts. Average price target: US$38.44.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 24,548 of 26,897 companies
20.2
score / 100
Value
12
Quality
29
FCF yld-25%
Earn yld-12%
EV/EBITDA·
ROE-47%
Gross mgn53%
Net mgn-41%
Debt/EBITDA·
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

US$16.04
Analyst consensus
9 analysts
Strong buy
US$30.00Target US$38.44(+140%)US$54.00
Income statement
RevenueUS$92.4M
Gross profitUS$48.8M53% margin
EBITDA-US$32.2M-35% margin
Net income-US$37.7M-30.4% margin
Valuation
PER (forward)-7.5x
P/Book3.0x
Beta0.40
Balance sheet & cash
Market capUS$313M
Total debtUS$1.8M
Free Cash Flow-US$76.4M
Debt / Equity1%
Profitability & ownership
ROE-47.0%
ROA-18.9%
% insiders18.2%
% institutions7.9%
Last declaration on 5 November 2026
Declarations16 total
  • ◇
    DirectorExecutives
    0SEC
    2,000 shares0Class A Ordinary Share, par value $0.0015 per shareSEC:0001628280-26-070656:0
  • ◇
    DirectorExecutives
    0SEC
    2,000 shares0Class A Ordinary Share, par value $0.0015 per shareSEC:0001628280-26-065170:0
  • ◇
    Chief Financial OfficerExecutives
    0SEC
    7,635 shares0Class A Ordinary Share, par value $0.0015 per shareSEC:0001628280-26-064363:0
  • ◇
    DirectorExecutives
    0SEC
    2,000 shares0Class A Ordinary Share, par value $0.0015 per shareSEC:0001628280-26-060618:0
  • ▲
    CFO of IM8 (US) LLCExecutives
    381,420 USD51SEC
    18,000 shares@ US$21.190.10% mcap76.6% of flowClass A Ordinary Share, par value $0.0015 per shareSEC:0001628280-26-058994:0
    Canonical exit: 22 Nov 2026 (T+90)
  • ▲
    CFO of IM8 (US) LLCExecutives
    116,280 USD44SEC
    5,100 shares@ US$22.800.031% mcap23.4% of flowClass A Ordinary Share, par value $0.0015 per shareSEC:0001628280-26-058994:1
    Canonical exit: 23 Nov 2026 (T+90)
  • ◇
    Chief Financial OfficerExecutives
    0SEC
    45,815 shares0Class A Ordinary Share, par value $0.0015 per shareSEC:0001628280-26-058762:1
  • ●
    Chief Executive OfficerExecutives
    0SEC
    49,912 shares0Class A Ordinary Share, par value $0.0015 per shareSEC:0001628280-26-058760:1
  • ◇
    Chief Financial OfficerExecutives
    33SEC
    32,736 shares100.0% of flowClass A Ordinary Share, par value $0.0015 per shareSEC:0001628280-26-058762:0
  • ◇
    Chief Executive OfficerExecutives
    28SEC
    53,953 shares0.0% of flowClass A Ordinary Share, par value $0.0015 per shareSEC:0001628280-26-058760:0
  • ▲
    Chief Executive OfficerExecutives
    137,325 USD34SEC
    7,500 shares@ US$18.310.036% mcap27.4% of flowClass A Ordinary Share, par value $0.0015 per shareSEC:0001628280-26-058760:2
    Canonical exit: 18 Nov 2026 (T+90)
  • ▲
    Chief Executive OfficerExecutives
    125,400 USD35SEC
    6,000 shares@ US$20.900.033% mcap25.0% of flowClass A Ordinary Share, par value $0.0015 per shareSEC:0001628280-26-058760:3
    Canonical exit: 22 Nov 2026 (T+90)
  • ▲
    Chief Executive OfficerExecutives
    239,273 USD39SEC
    11,181 shares@ US$21.400.064% mcap47.7% of flowClass A Ordinary Share, par value $0.0015 per shareSEC:0001628280-26-058760:4
    Canonical exit: 22 Nov 2026 (T+90)
  • ◇
    DirectorExecutives
    0SEC
    2,001 shares0Class A Ordinary Share, par value $0.0015 per shareSEC:0001628280-26-053017:0
  • ◇
    DirectorExecutives
    0SEC
    2,000 shares0Class A Ordinary Share, par value $0.0015 per shareSEC:0001628280-26-047428:0
  • ◇
    DirectorExecutives
    0SEC
    15,873 sharesClass A Ordinary Share, par value $0.0015 per shareSEC:0001628280-26-043436:0

16 of 16 declarations

About Prenetics Global Ltd

Prenetics Global Ltd is a company focused on genetic testing and digital health solutions. It operates on the XNAS stock market.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations